Regen Biopharma issues 77.85M shares to settle $68,723 in debt and fees

Regen BioPharma Inc

Issued 77,849,847 common shares between Feb 4-27, 2026 for $53,474 principal, $4,249 interest, $11,000 fees.
Shares were issued in unregistered private placement under Section 4(a)(2) with no underwriter or commission.
Post-issuance outstanding shares total 212,318,424 as of March 3, 2026.
Implied issuance price of approximately $0.0009 per share, suggesting severe dilution for existing holders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.